Anavex Life Sciences Corp (AVXL)

[nidan7500]

IMO, Dr. M. chose Rett trial to go first b/c of the dramatic positive impact which might be generated. I also believe that end points for A2-73 trials are likely to include patients condition as much as they will test scores (MMSE example). Quality of life will be huge as a key metric for the new FDA trials acceptance criteria, IMO.

It will be refreshing if we have patients being interviewed about how they are feeling vs a caregiver discussion on their deepening state misery.

Is it too far down the road? Maybe, but Rett results may present results that put the critics to rest. IMO, that is why he picked it to go first.